Mint Tower Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-8,400
Closed -$2.21M 294
2022
Q4
$2.21M Buy
8,400
+600
+8% +$161K 0.2% 90
2022
Q3
$1.76M Sell
7,800
-4,600
-37% -$1.12M 0.14% 164
2022
Q2
$3.02M Sell
12,400
-1,300
-9% -$319K 0.24% 80
2022
Q1
$3.31M Buy
+13,700
New +$3.15M 0.31% 54
2020
Q2
Sell
-10,000
Closed -$2.03M 255
2020
Q1
$2.03M Hold
10,000
0.39% 55
2019
Q4
$2.41M Hold
10,000
0.32% 92
2019
Q3
$1.94M Buy
+10,000
New +$1.92M 0.28% 88
2019
Q1
Sell
-100
Closed -$1.95M 185
2018
Q4
$1.95M Sell
100
-9,900
-99% -$1.93M 0.25% 83
2018
Q3
$2.07M Sell
10,000
-10,000
-50% -$1.97M 0.26% 81
2018
Q2
$3.69M Hold
20,000
0.49% 50
2018
Q1
$3.41M Buy
+20,000
New +$3.67M 0.46% 36

Other funds holding AMGN

Mint Tower Capital Management's AMGN Position: Q1 2023 in Review

Mint Tower Capital Management sold out of Amgen (AMGN) in Q1 2023, closing a stake of 1,458 shares — an estimated $383K sold.

Mint Tower Capital Management first reported a position in AMGN in Q1 2018 and held it in 4 quarters. The position peaked at $1M in Q3 2022. 2,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • Mint Tower Capital Management reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
  • Mint Tower Capital Management sold 1,458 Amgen shares in Q1 2023, an estimated $383K.
  • Mint Tower Capital Management first reported a position in Amgen in Q1 2018 and held it in 4 quarters.
  • Mint Tower Capital Management's Amgen position peaked at $1M in Q3 2022.
  • 2,434 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on Mint Tower Capital Management's 13F filing for Q1 2023, filed 9 May 2023.